TRANSURETHRAL EN BLOCK RESECTION OF THE BLADDER WALL TUMOR
Abstract
The goal of the research: to evaluate short-and long-term treatment outcomes in patients with superficial bladder cancer, who underwent transurethral en block resection of the bladder wall tumor. Material and methods. Surgical treatment results were assessed in 270 patients with bladder cancer from 2003 to 2012. All patients were divided into 2 groups. Group I consisted of 94 patients who underwent transurethral en block resection of the bladder wall tumor. Group II (the control group) composed of 176 patients who received the conventional transurethral resection. Results. Local recurrence occurred 1.4-fold less frequently in Group I than in Group II patients (47.7 versus 34.0 %, p<0.05), and disease progression occurred 4-fold less frequently in Group I than in the control group (8.5 versus 2.1 %, p<0.001). Moreover, the Group I patients had a longer time to disease progression than the Group II patients (6.1 ± 3.1 versus 32.5 ± 75 months, p<0.05). Conclusion. Transurethral en block resection of the bladder wall tumor allows the depth of invasion to be exactly measured and the incidence of recurrence to be decreased.
About the Authors
М. Yu. Ulyanin
Republic Clinical Cancer Center, Kazan, the Republic of Tatarstan;
Privolzhskiy branch of the N.N. Blokhin Russian Cancer Research Center, Kazan;
Kazan State Medical Academy
Russian Federation
Ulyanin Mikhail Yurievich, oncologist
Russian Federation
Ulyanin Mikhail Yurievich, oncologist
G. Т. Basiashvili
Republic Clinical Cancer Center, Kazan, the Republic of Tatarstan;
Privolzhskiy branch of the N.N. Blokhin Russian Cancer Research Center, Kazan;
Kazan State Medical Academy
Russian Federation
Basiashvili Georgy Tarielovich, oncologist
Russian Federation
Basiashvili Georgy Tarielovich, oncologist
R. Sh. Khasanov
Republic Clinical Cancer Center, Kazan, the Republic of Tatarstan;
Privolzhskiy branch of the N.N. Blokhin Russian Cancer Research Center, Kazan;
Kazan State Medical Academy
Russian Federation
Khasanov Rustem Shamilyevich, MD, DSc, Honored Physician of the Russian Federation, and the Republic of Kazakhstan, Head Physician of the Republic Clinical Cancer Center Kazan, the Republic of Kazakhstan; Director of Privolzhskiy branch of the N.N. Blokhin Russian Cancer Research Center, Head of Department of Oncology, Radiology and Palliative Medicine of Kazan State Medical Academy
Russian Federation
Khasanov Rustem Shamilyevich, MD, DSc, Honored Physician of the Russian Federation, and the Republic of Kazakhstan, Head Physician of the Republic Clinical Cancer Center Kazan, the Republic of Kazakhstan; Director of Privolzhskiy branch of the N.N. Blokhin Russian Cancer Research Center, Head of Department of Oncology, Radiology and Palliative Medicine of Kazan State Medical Academy
М. V. Burmistrov
Republic Clinical Cancer Center, Kazan, the Republic of Tatarstan;
Privolzhskiy branch of the N.N. Blokhin Russian Cancer Research Center, Kazan;
Kazan State Medical Academy
Russian Federation
Burmistrov Mikhail Vladimirovich, MD, Professor, Department of Oncology, Radiology and Palliative Medicine of Kazan State Medical Academy
Russian Federation
Burmistrov Mikhail Vladimirovich, MD, Professor, Department of Oncology, Radiology and Palliative Medicine of Kazan State Medical Academy
I. G. Gataullin
Republic Clinical Cancer Center, Kazan, the Republic of Tatarstan;
Privolzhskiy branch of the N.N. Blokhin Russian Cancer Research Center, Kazan;
Kazan State Medical Academy
Russian Federation
Gataullin Ilgiz Gabdullovich, MD, Professor, Department of Oncology, Radiology and Palliative Medicine of Kazan State Medical Academy
Russian Federation
Gataullin Ilgiz Gabdullovich, MD, Professor, Department of Oncology, Radiology and Palliative Medicine of Kazan State Medical Academy
References
1. Derzhavets L.A. Laboratory indices and survival of urinary bladder cancer patients // Sibirskij onkologicheskij zhurnal. 2013. № 4. P. 12–16. [in Russian]
2. Cancer incidence in Russia in 2013 (morbidity and mortality) / Eds. A.D. Kaprin, V.V. Starinskij, G.V. Petrova. M., 2015. P. 250. [in Russian]
3. Martov A.G., Ergakov D.V., Baykov N.A., Pominalnaya V.M, Solomatnikov I.A. Transurethral en bloc resection of bladder tumors // Onkourologija. 2015. Vol. 1 (1). P. 41–49. [in Russian]
4. Allard P., Bernard P., Fradet Y., Tetu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index // Br. J. Urol. 1998. Vol. 81 (5). P. 692–698.
5. Domínguez G., Carballido J., Silva J., Silva J.M., García J.M., Menéndez J., Provencio M., España P., Bonilla F. p14ARF promoter hypermetylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients // Clin. Cancer Res. 2002. Vol. 8 (4). P. 980–985.
6. Epstein J.I., Amin M.B., Reuter V.R., Mostofi F.K. The world health organization/international society of urological patology consensus classification of urotelial (transitional cell) neoplasms of the urinary bladder // Am. J. Surg. Pathol. 1998. Vol. 22 (12). P. 1435–1448.
7. Herr H.W., Donat M.S. Quality control in transurethral resection of bladder tumors // BJU Int. 2008. Vol. 102 (9. Pt. B). P. 1242–1246. doi: 10.1111/j.1464-410X.2008.07966.x.
8. Hu Z., Mudaliar K., Quek M.L., Paner G.P., Barkan G.A. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence // Ann. Diagn. Pathol. 2014. Vol. 18 (2). P. 49–52. doi: 10.1016/j.anndiagpath.2013.11.002.
9. Kawada T., Ebihara K., Suzuki T., Imai K., Yamanaka H. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode // J. Urol. 1997. Vol. 157 (6). P. 2225–2226.
10. Lodde M., Lusuardi L., Palermo S., Signorello D., Maier K., Hohenfellner R., Pycha A. En bloc transurethral resection of bladder tumors: use and limits // Urology. 2003. Vol. 62 (6). P. 1089–1091.
11. Millán-Rodríguez F., Chéchile-Toniolo G., Salvador-Bayarri J., Palou J., Algaba F., Vicente-Rodríguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence // J. Urol. 2000. Vol. 164 (3. Pt 1.) P. 680–684.
12. Muto G., Collura D., Giacobbe A., D’Urso L., Muto G.L., Demarchi A., Coverlizza S., Castelli E. Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages // J. Urology. 2014. Vol. 83 (4). P. 851–855. doi: 10.1016/j.urology.2013.12.022.
13. Naselli A., Introini C., Germinale F., Spina B., Puppo P. En bloc transurethral resection of bladder lesions: a trick to retrieve specimens upto 4.5 cm // BJU Int. 2012. Vol. 109 (6). P. 960–963. doi: 10.1111/j.1464410X.2012.10982.x.
14. Saito S. Transurethral en bloc resection of bladder tumors // J. Urol. 2001. Vol. 166 (6). P. 2148–2150.
15. Upadhyay R., Kapoor R., Srivastava A., Krishnani N., Mandhani A. Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen? // Indian J. Urol. 2012. Vol. 28 (3). P. 275–279. doi: 10.4103/0970-1591.102700.
Review
For citations:
Ulyanin М.Yu., Basiashvili G.Т., Khasanov R.Sh., Burmistrov М.V., Gataullin I.G. TRANSURETHRAL EN BLOCK RESECTION OF THE BLADDER WALL TUMOR. Siberian journal of oncology. 2015;1(5):30-36. (In Russ.)
Views:
705
Email this article 
